- Home
- RNAC vs EHAB Comparison
RNAC vs EHAB Comparison
Compare RNAC & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAC
- EHAB
- Stock Information
- Founded
- RNAC 2007
- EHAB 2014
- Country
- RNAC United States
- EHAB United States
- Employees
- RNAC N/A
- EHAB N/A
- Industry
- RNAC Biotechnology: Pharmaceutical Preparations
- EHAB Hospital/Nursing Management
- Sector
- RNAC Health Care
- EHAB Health Care
- Exchange
- RNAC Nasdaq
- EHAB Nasdaq
- Market Cap
- RNAC 472.7M
- EHAB 397.2M
- IPO Year
- RNAC 2016
- EHAB N/A
- Fundamental
- Price
- RNAC $17.33
- EHAB $7.35
- Analyst Decision
- RNAC Strong Buy
- EHAB Hold
- Analyst Count
- RNAC 7
- EHAB 6
- Target Price
- RNAC $40.80
- EHAB $9.15
- AVG Volume (30 Days)
- RNAC 107.5K
- EHAB 402.1K
- Earning Date
- RNAC 11-07-2024
- EHAB 11-06-2024
- Dividend Yield
- RNAC N/A
- EHAB N/A
- EPS Growth
- RNAC N/A
- EHAB N/A
- EPS
- RNAC N/A
- EHAB N/A
- Revenue
- RNAC $47,938,000.00
- EHAB $1,037,200,000.00
- Revenue This Year
- RNAC $69.22
- EHAB $2.55
- Revenue Next Year
- RNAC N/A
- EHAB $3.63
- P/E Ratio
- RNAC N/A
- EHAB N/A
- Revenue Growth
- RNAC N/A
- EHAB N/A
- 52 Week Low
- RNAC $11.67
- EHAB $6.85
- 52 Week High
- RNAC $42.60
- EHAB $11.74
- Technical
- Relative Strength Index (RSI)
- RNAC 39.04
- EHAB 45.67
- Support Level
- RNAC $15.50
- EHAB $6.93
- Resistance Level
- RNAC $22.20
- EHAB $8.09
- Average True Range (ATR)
- RNAC 1.65
- EHAB 0.35
- MACD
- RNAC -0.56
- EHAB 0.02
- Stochastic Oscillator
- RNAC 24.43
- EHAB 35.71
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
About EHAB Enhabit Inc.
Enhabit Inc provides home health and hospice services in the United States. It offers care where patients prefer it: in their homes. It operates business in two segments: home health and hospice. Its home health segment include a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates the majority of its revenue from the Home Health segment.